期刊文献+

阿托伐他汀对急性脑梗死患者临床及血流变学的影响 被引量:2

Effect of Atorvastatin on Clinical and Blood Rheology in Patient With Acute Cerebral Infarction
下载PDF
导出
摘要 目的观察阿托伐他汀对急性脑梗死患者临床及血流变学的影响。方法将人选的急性脑梗死患者120例随机分为治疗组和对照组各60例,对照组用常规治疗方法(复方丹参注射液、依达拉奉注射液和奥扎格雷钠注射液静脉滴注,口服肠溶阿司匹林片等);治疗组在常规治疗的基础上加阿托伐他汀钙口服。两组均连续治疗3个月。观察两组治疗前后临床疗效(神经功能缺损程度改变)及血流变学等指标的变化。结果治疗组总有效率明显高于对照组(p<0.05);治疗后治疗组TC、TG、LDL—c极显著低于对照组(P<0.01);治疗组全血低切黏度明显低于对照组(P<0.05)。结论阿托伐他汀能有效调整血脂代谢,改善神经缺损评分,促进脑细胞功能恢复,且安全性好。 Objective To observe the clinical effect of atorvastatin in the treatment of acute cerebral infarction and observe the clinical impact of blood rheology. Methods 120 cases of patients with acute cerebral infarction were randomly divided into 60 cases of treatment group and 60 cases of control group. The control group got conventional treatment (compound Danshen injection, Edaravone Ozagrel injection and intravenous drip injection Note, oral enteric - coated aspirin tablets, etc. ). The pationts in treatment group were given atorv-astatin calcium based on the conventional treatment. Patients in the two groups were treated for 3 months. The clinical efficacy and blood rheology indicators were observed. Results The total effective rate of the treatment group was significantly higher than that of the control group (P 〈0.05). TC, TG, LDL - C was significantly lower than those in the control group (P 〈0. O1 ). The whole blood viscosity was significantly lower than that in the control group (P 〈 0.05). Conclusion Atorvastatin can effectively adjust the lipid metabolism and improve the neurological deficit scores, and promote functional recovery of brain cells, and has good security.
作者 胡浩
出处 《医学研究杂志》 2009年第12期71-73,共3页 Journal of Medical Research
关键词 急性脑梗死 血液流变学 血脂代谢 阿托伐他汀 Acute cerebral infarction Blood rheology Lipid metabolism Atorvastatin
  • 相关文献

参考文献6

二级参考文献98

  • 1李宾公,曾秋棠,晏凯利.骨髓干细胞动员治疗大鼠急性心肌梗死的实验研究[J].中国急救医学,2005,25(4):268-271. 被引量:3
  • 2Chun-ling FAN Ping-jin GAO Zai-qian CHE Jian-jun LIU Jian WEI Ding-liang ZHU.Therapeutic neovascularization by autologous transplantation with expanded endothelial progenitor cells from peripheral blood into ischemic hind limbs[J].Acta Pharmacologica Sinica,2005,26(9):1069-1075. 被引量:19
  • 3Simes J, Furberg CD, Braunwald E, Davis BR, Ford I, Tonkin A, et al.Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels.The Prospective Pravastatin Pooling project.Eur Heart J, 2002, 23 (3):207-215
  • 4Scandinavian Simvastatin Survival Study Group.Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study (4S).Lancet, 1994, 344:1 383-389
  • 5Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al.Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels:results of AFCAPS/TexCAPS.Air Force/Texas Coronary Atherosclerosis Prevention Study.J Am Med Assoc, 1998, 279 (20):1 615-622
  • 6Plutzky J, Ridker PM.Statins for Stroke:The Second Story? Circulation, 2002, 103 (3):348-350
  • 7Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, et al.Effect of pravastatin on outcomes after cardiac transplantation.N Engl J Med, 1995, 333 (10):621-627
  • 8Wenke K, Meiser B, Thiery J, Nagel D, Scheidt WV, Steinbeck G, et al.Simvastatin reduces graft vessel disease and mortality after heart transplantation.Circulation, 1997, 96 (5):1 398-402
  • 9Strandberg TE, Vanhanen H, Tikkanen MJ.Effect of statins on C-reactive protein with coronary artery disease.Lancet, 1999, 353(9147):118-119
  • 10Rider PM, Rifai N, Pfeffer M, Sacks F, Braunwald E.For the cholesterol and recurrent event (CARE) investigators.Long-term effects of pravastatin on plasma concentration of C-reactive protein.Circulation, 1999, 100 (3):230-235

共引文献192

同被引文献19

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部